The subject of the call for tenders is the conclusion of pharmaceutical framework discount agreements in accordance with Section 130a paragraph 8 SGB V for the provision of medicines to KKH insured persons.

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).

In the case of the aforementioned lot, the intention is to conclude a discount contract with a pharmaceutical company (as a single bidder or as a group of bidders made up of pharmaceutical companies).